Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

19 Jan 2012 07:00

RNS Number : 8017V
Xaar PLC
19 January 2012
 



 

 

 

FOR IMMEDIATE RELEASE

19 January 2012

 

 

 

Xaar plc

 

 

YEAR END TRADING UPDATE

 

 

Xaar plc ("Xaar" or "the Group" or "the Company"), the inkjet printing technology group headquartered in Cambridge, announces an update on trading for the year ended 31 December 2011.

 

Trading for the fourth quarter of the year was slightly ahead of the Board's expectations, leading to a strong performance for the full year 2011.

 

Xaar expects to announce revenue of approximately £69 million for 2011, an increase of over 25% compared to 2010 (£54.7 million).

 

Revenue growth in 2011 was achieved mainly by increased sales into the industrial segment. Demand for Xaar's technology in this segment is principally driven by the conversion of ceramic tile printing to digital inkjet from analogue processes. During the year, Xaar made good progress with the capacity expansion programme to support this demand and the programme remains on track to continue to deliver the planned incremental capacity during the first half of 2012.

 

As expected, product sales into the graphic arts segment declined in 2011 by approximately 15% compared to 2010. As previously described, this decline reflects market maturity and competitive pressure.

 

The Group continues to maintain a strong balance sheet with net cash at 31 December 2011 of £17.4 million (30 June 2011 - £20.6 million; 31 December 2010 - £22.0 million).

 

The detailed results for 2011 are expected to be announced on 20 March 2012.

 

Board changes

 

As previously announced Phil Eaves, Sales and Marketing Director, informed the Company in 2011 of his intention to retire from full time employment in June 2012. Following an extensive search process, the Company is pleased to announce that Richard Barham has been appointed Sales and Marketing Director and member of the Xaar board with effect from 5 March 2012. After completion of a handover period, Phil Eaves will continue to support the Company in a consultant role until 30 June 2012.

 

Ian Dinwoodie, Chief Executive commented:

 

'On behalf of everyone at Xaar, I would like to thank Phil for his efforts and contribution over the last 7 years during which our revenues have grown significantly. We all wish him well for the future.

 

I am pleased to welcome Richard to the Board, who brings a wealth of experience gained through 25 years spent in numerous sectors of the Imaging and Printing industries.'

Since 1986, Mr Barham has held a range of sales, marketing and management positions at Agfa Graphics NV, where most recently, since February 2008, he acted as Vice President of the Inkjet Division where he was responsible for turning the business around and integrating a major acquisition.

 

There is no further information concerning Mr Barham which requires disclosure under rule 9.6.13 of the UK Listing Authority Listing Rules.

 

 

END

 

CONTACTS

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Alex Bevis, Finance Director

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Simon Bloomfield

020-7367-8888 / 07771-758517

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDVLFFLFFFBBB
Date   Source Headline
1st May 20192:21 pmRNSTotal Voting Rights
1st May 201910:15 amRNSGrant of Options
30th Apr 20192:59 pmRNSHolding(s) in Company
2nd Apr 201910:31 amRNSTotal Voting Rights
21st Mar 20197:00 amRNSXaar plc 2018 Full Year Results
11th Mar 20197:00 amRNSTrading Update
1st Mar 20199:53 amRNSTotal Voting Rights
1st Feb 20191:12 pmRNSTotal Voting Rights
2nd Jan 20194:48 pmRNSBlock Listing Six Monthly Return
2nd Jan 20194:45 pmRNSTotal Voting Rights
2nd Jan 201912:07 pmRNSSecond Price Monitoring Extn
2nd Jan 201912:02 pmRNSPrice Monitoring Extension
28th Dec 20187:00 amRNSTrading Update
3rd Dec 20184:12 pmRNSTotal Voting Rights
20th Nov 20187:00 amRNSNEOS AND KELENN TECHNOLOGY ADOPT XAAR 5601
5th Nov 201811:12 amRNSHolding(s) in Company
1st Nov 20183:21 pmRNSTotal Voting Rights
24th Oct 20187:00 amRNSAppointment of CFO and Company Secretary
11th Oct 201812:07 pmRNSSecond Price Monitoring Extn
11th Oct 201812:02 pmRNSPrice Monitoring Extension
10th Oct 201812:07 pmRNSSecond Price Monitoring Extn
10th Oct 201812:02 pmRNSPrice Monitoring Extension
1st Oct 20185:20 pmRNSTotal Voting Rights
5th Sep 20187:00 amRNSW&H Chooses Xaar 5601
5th Sep 20187:00 amRNSXaar 2018 Interim Results
4th Sep 20188:30 amRNSTotal Voting Rights
4th Sep 20188:05 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSTrading Update
1st Aug 20182:40 pmRNSTotal Voting Rights
12th Jul 20187:00 amRNSAnnouncement of 3D Printing Joint Investment
2nd Jul 20185:39 pmRNSBlock listing Interim Review
2nd Jul 20185:37 pmRNSTotal Voting Rights
27th Jun 20187:00 amRNSTrading Statement
1st Jun 20182:25 pmRNSTotal Voting Rights
30th May 20187:00 amRNSBoard Change
22nd May 201812:12 pmRNSResult of AGM
1st May 20185:02 pmRNSTotal Voting Rights
11th Apr 201812:02 pmRNSPrice Monitoring Extension
5th Apr 20189:38 amRNSGrant of Options
3rd Apr 201812:26 pmRNSTotal Voting Rights
3rd Apr 201810:54 amRNSBoard Change
23rd Mar 20182:10 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSXaar plc 2017 Full Year Results
20th Mar 20181:25 pmRNSHolding(s) in Company
12th Mar 201810:58 amRNSHolding(s) in Company
1st Mar 20183:57 pmRNSTotal Voting Rights
2nd Feb 20188:00 amRNSNotice of Scheduled Results
1st Feb 201811:11 amRNSTotal Voting Rights
5th Jan 20187:00 amRNSBlock listing Interim Review
5th Jan 20187:00 amRNSIssue of Equity - Share Scheme and Block Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.